|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
Executive Committee: Cornerstone Therapeutics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Jon Zwinski
CEO | Chief Executive Officer | - | 2020-12-31 |
| Chief Tech/Sci/R&D Officer | 76 | - |
Company details: Cornerstone Therapeutics, Inc.
Generic Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.10% | -0.77% | +17.58% | +70.16% | 48.43B | |
| -3.26% | -5.31% | +52.47% | +114.13% | 39.72B | |
| -0.60% | -0.94% | -7.29% | +17.35% | 12.25B | |
| -2.75% | +1.88% | +14.81% | +76.92% | 11.84B | |
| -0.58% | -0.77% | +29.90% | +135.00% | 9.06B | |
| +1.56% | +5.52% | +23.69% | +41.38% | 7.57B | |
| +0.52% | +2.08% | +42.23% | -13.42% | 7.18B | |
| -0.07% | +1.72% | +13.39% | +190.65% | 6.84B | |
| -2.51% | -3.14% | -30.53% | +23.54% | 5.77B | |
| Average | -0.87% | +1.46% | +17.36% | +72.86% | 16.52B | |
| Weighted average by Cap. | -1.20% | +1.00% | +24.83% | +80.29% |
- Stock Market
- Stocks
- Stock
- Company Cornerstone Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
